HomeProductsBioactive CompoundsNF-kB SignalingNF-??BAtiprimod
Chemical structure of CAS 123018-47-3

Atiprimod

CAS No.123018-47-3
MDL No.N/A
MFC22H44N2
MW336.60
InChI KeySERHTTSLBVGRBY-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.123018-47-3
Product NameAtiprimod

Associated Conditions

neuroendocrine carcinoma·multiple myeloma·cancer
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

A severe combined immunodeficient-hu in vivo mouse model of human primary mantle cell lymphoma.

Clinical cancer research : an official journal of the American Association for Cancer Research • Vol. 14, Issue 7 • 2008
PMID: 18381957DOI: 10.1158/1078-0432.CCR-07-4409

Biological pathways and in vivo antitumor activity induced by Atiprimod in myeloma.

Leukemia • Vol. 21, Issue 12 • 2007
PMID: 17882285DOI: 10.1038/sj.leu.2404912

Atiprimod inhibits the growth of mantle cell lymphoma in vitro and in vivo and induces apoptosis via activating the mitochondrial pathways.

Blood • Vol. 109, Issue 12 • 2007
PMID: 17317853DOI: 10.1182/blood-2006-12-063958

Atiprimod: a multi-functional drug candidate for myeloid and other malignancies.

Leukemia research • Vol. 31, Issue 1 • 2007
PMID: 16860863DOI: 10.1016/j.leukres.2006.06.007

Documentation